Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michel L. Hijmering"'
Autor:
Michel L. Hijmering, Erik S.G. Stroes, Barbara A. Hutten, Jobien K. Olijhoek, Peter J. Blankestijn, Ton J. Rabelink
Publikováno v:
Journal of the American College of Cardiology, 39(4), 683-688. Elsevier USA
OBJECTIVES We sought to evaluate whether increased sympathetic outflow may interfere with flow-mediated dilation (FMD). BACKGROUND Endothelial function, assessed as FMD, is frequently used as an intermediate end point in intervention studies. Many di
Autor:
Wobbe Hospes, Alexander J. Spanjersberg, Peter G. J. ter Horst, Marieke Aalbers, Michel L. Hijmering
Publikováno v:
International journal of clinical pharmacy. 37(4)
Backgound Patients are at risk for severe postoperative infections after coronary artery bypass graft (CABG) surgery. Clinical laboratory data showed that unbound plasma concentrations of cefuroxime were not always adequate, therefore we developed a
Autor:
Michel L. Hijmering, Erik S.G. Stroes, Gerard Pasterkamp, M. Sierevogel, Jan-Dirk Banga, Ton J. Rabelink
Publikováno v:
Atherosclerosis. 157:369-373
Flow mediated vasodilatation (FMD), a non-invasive tool to assess endothelial function, has been shown to have prognostic value for the development of cardiovascular disease. Conventional B-mode ultrasonography has been criticised for its 'limited' r
Autor:
Marina L. H. Honing, Ton J. Rabelink, Paul J. Morrison, Yonghong P. Yang, Robert J. Padley, David E. Ballard, Michel L. Hijmering
Publikováno v:
Journal of the American Society of Nephrology. 11:1498-1504
Endothelin (ET-1) acts as a potent vasoconstrictor in the human kidney, and this vasoconstriction could contribute to the ischemia seen in acute renal failure. In animal studies, the vasoactive properties of ET-1 are known to be ET A receptor-and/or
Autor:
Ton J. Rabelink, Michel L. Hijmering, Hanneke W Wilmink, Erik S.G. Stroes, Willem D. Erkelens, Jan Dirk Banga
Publikováno v:
Journal of the American College of Cardiology. 34(1):140-145
OBJECTIVES The purpose of this study was to determine whether endothelial dysfunction as a consequence of direct postprandial lipid response might be favorably influenced by angiotensin-converting enzyme inhibitors or angiotensin AT1 receptor antagon
Autor:
Michel L. Hijmering, Peter Boer, Ron Wever, Hendrik A. Koomans, K Versluis, Ton J. Rabelink, van Hedderik Rijn, Fija M. Lagerwerf, Erik S.G. Stroes, Marianne C. Verhaar, J.J.P. Kastelein
Publikováno v:
ResearcherID
Scopus-Elsevier
Scopus-Elsevier
Abstract —In patients with chronic renal failure (CRF), atherosclerosis is a major cause of cardiovascular morbidity and mortality. Generally, atherosclerosis has been associated with a reduced bioavailability of nitric oxide (NO). Experimental stu
Autor:
Robert Wever, Erik S.G. Stroes, M. A. M. J. van Zandvoort, E.E. van Faassen, Ton J. Rabelink, Michel L. Hijmering
Publikováno v:
FEBS Letters. 438:161-164
Using fluorescence optical and electron spin resonance spectroscopy, we have investigated the production of superoxide by bovine endothelial nitric oxide synthase (NOS). In contrast to neuronal NOS, the heme moiety is identified as the exclusive sour
Autor:
Peter G. J. ter Horst, Wobbe Hospes, Alexander J. Spanjersberg, Bob Wilffert, Daphne Bertholee, Michel L. Hijmering
Publikováno v:
International Journal of Clinical Pharmacy, 35(5), 798-804. SPRINGER
Objectives Patients with coronary artery bypass graft (CABG) surgery are at risk for severe postoperative infections. Prophylactic cefuroxime may help to reduce this risk, however sufficient concentrations, i.e. above the breakpoint (32 mg/L), are ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1a6337ce0444f6674e5f9bcb01fd0a
https://research.rug.nl/en/publications/da88a861-8fee-4462-a3ac-61cf83518624
https://research.rug.nl/en/publications/da88a861-8fee-4462-a3ac-61cf83518624
Autor:
Erik S.G. Stroes, Hein A. Koomans, Ton J. Rabelink, Ronald E. van Etten, Jaap J. Beutler, Michel L. Hijmering, Jacobine M. A. van Ampting
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 37(1)
Abstract —To evaluate whether ACE inhibition and angiotensin II type 1 blockade exert beneficial effects on NO availability independent of their blood pressure–lowering effect, we used a double-blind crossover design to study vascular function in
Autor:
Erik S.G. Stroes, Michel L. Hijmering, Jaap J. Beutler, Ton J. Rabelink, J. M.A. van Ampting, Hendrik A. Koomans
Publikováno v:
Journal of Hypertension. 18:S11